Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis

Cesare Hassan, Dk Rex, Gs Cooper, A Zullo, R Launois, R. Benamouzig

Risultato della ricerca: Contributo in rivistaArticolo in rivista

25 Citazioni (Scopus)

Abstract

Low-dose aspirin reduces colorectal cancer (CRC) incidence and mortality. Recently, the aspirin effect has been shown to occur primarily in the proximal colon. Colonoscopy has been either less effective or ineffective in the proximal compared to the distal colon. The authors assessed the cost-effectiveness of adding low-dose aspirin to a simulated screening with colonoscopy or sigmoidoscopy.
Lingua originaleEnglish
pagine (da-a)1172-1179
Numero di pagine8
RivistaEGUT
Volume61
DOI
Stato di pubblicazionePubblicato - 2012
Pubblicato esternamenteYes

Keywords

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin
  • Colonoscopy
  • Colorectal Neoplasms
  • Cost-Benefit Analysis
  • Dose-Response Relationship, Drug
  • Humans
  • Male
  • Mass Screening
  • Middle Aged
  • Neoplasm Staging
  • Primary Prevention
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis'. Insieme formano una fingerprint unica.

Cita questo